All Stories

  1. Variance Estimation for Weighted Average Treatment Effects
  2. Development of a natural language processing algorithm to extract social determinants of health from clinician notes
  3. Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
  4. Assessing racial disparities in healthcare expenditure using generalized propensity score weighting
  5. Observations from Statistical Review Editors: A Commentary
  6. Trial Design with Win Statistics for Multiple Time-to-Event Endpoints with Hierarchy
  7. Causal inference in the absence of positivity: The role of overlap weights
  8. Overlap, matching, or entropy weights: what are we weighting for?
  9. Variance estimation for the average treatment effects on the treated and on the controls
  10. Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry
  11. US Surveillance of Acute Ischemic Stroke Patient Characteristics, Care Quality, and Outcomes for 2019
  12. Sex Differences in Endovascular Therapy for Ischemic Stroke: Results From the Get With The Guidelines–Stroke Registry
  13. Food insecurity among university students in the United States amidst the COVID-19 pandemic
  14. Robust statistical inference for matched win statistics
  15. Temporal Trends in Racial and Ethnic Disparities in Endovascular Therapy in Acute Ischemic Stroke
  16. Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines – Atrial Fibrillation (GWTG-AFIB) registry
  17. Seasonal Variation of Atrial Fibrillation Admission and Quality of Care in the United States
  18. Comfort Measures Only in Myocardial Infarction: Prevalence of This Status, Change Over Time, and Predictors From a Nationwide Study
  19. Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure
  20. Frequency, Characteristics, and Outcomes of Endovascular Thrombectomy in Patients With Stroke Beyond 6 Hours of Onset in US Clinical Practice
  21. Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload
  22. Sex Differences in Ablation Strategy, Lesion Sets, and Complications of Catheter Ablation for Atrial Fibrillation: An Analysis From the GWTG-AFIB Registry
  23. Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke
  24. Association Between 2010 Medicare Reform and Inpatient Rehabilitation Access in People With Intracerebral Hemorrhage
  25. Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation
  26. Racial differences in patient perception of interactions with providers are associated with health outcomes in type II diabetes
  27. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association’s COVID-19 Cardiovascular Disease Registry
  28. Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry
  29. Patterns of Care for Atrial Fibrillation Before, During, and at Discharge From Hospitalization
  30. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines–Atrial Fibrillation Registry
  31. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization
  32. Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
  33. Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries
  34. Procedural Patterns and Safety of Atrial Fibrillation Ablation
  35. Regression with a right‐censored predictor using inverse probability weighting methods
  36. Propensity score weighting under limited overlap and model misspecification
  37. Hospital Factors Associated With Interhospital Transfer Destination for Stroke in the Northeast United States
  38. Hospital distance, socioeconomic status, and timely treatment of ischemic stroke
  39. Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients
  40. Thrombolysis in young adults with stroke
  41. A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients
  42. Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke
  43. Cox regression model with randomly censored covariates
  44. The win ratio: On interpretation and handling of ties
  45. Ischemic Stroke Transfer Patterns in the Northeast United States
  46. Abstract WP180: Association Between Medicare Reform and Access to Rehabilitation in Ischemic Stroke Patients
  47. Abstract WP372: International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke
  48. Temperature and Precipitation Associate With Ischemic Stroke Outcomes in the United States
  49. SHARED SAVINGS ACOS AND PALLIATIVE CARE FOR ISCHEMIC STROKE PATIENTS: FINDINGS FROM GET WITH THE GUIDELINES-STROKE
  50. Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery
  51. Shock Index Predicts Patient‐Related Clinical Outcomes in Stroke
  52. Sex and Racial Disparities in Cardiac Rehabilitation Referral at Hospital Discharge and Gaps in Long‐Term Mortality
  53. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement
  54. Abstract 131: Impact of Concomitant Use of Antiplatelet and Anticoagulation Therapies on Outcomes in Patients With Intracerebral Hemorrhage
  55. Abstract TMP75: Clinical Care and Outcomes of Asian Acute Ischemic Stroke Patients
  56. Abstract WP297: Increasing Interfacility Transfers Among Northeastern Hospitals in the Care of Stroke Patients
  57. Optimal Weighted Wilcoxon–Mann–Whitney Test for Prioritized Outcomes
  58. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure
  59. Association of Surgeon Age and Experience With Congenital Heart Surgery Outcomes
  60. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke
  61. Instrumental variable estimation of causal odds ratios using structural nested mean models
  62. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population
  63. Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
  64. Combining mortality and a non-mortality continuous endpoint: a test statistic
  65. Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes
  66. Complications after a transcatheter aortic valve replacement and their impact on mortality
  67. Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: Findings From Get With The Guidelines‐Stroke
  68. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG‐CAD) Registry
  69. PULMONARY HYPERTENSION IS ASSOCIATED WITH WORSE TAVR OUTCOMES INDEPENDENT OF COPD: REPORT FROM THE TVT REGISTRY
  70. Gait speed predicts mortality in transcatheter aortic valve replacement
  71. Participation in light of anticipating benefits: how can it blurry findings?
  72. Power and sample size calculations for the Wilcoxon-Mann-Whitney test in the presence of death-censored observations
  73. Evaluating marker-guided treatment selection strategies
  74. Inhibition of the NFAT Pathway Alleviates Amyloid Beta Neurotoxicity in a Mouse Model of Alzheimer's Disease
  75. Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain
  76. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans